Charles Schwab’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-465,962
| Closed | -$23.8M | – | 3528 |
|
|
2024
Q4 | $23.8M | Buy |
465,962
+11,990
| +3% | +$589K | ﹤0.01% | 1606 |
|
|
2024
Q3 | $18.7M | Buy |
453,972
+1,783
| +0.4% | +$85.6K | ﹤0.01% | 1727 |
|
|
2024
Q2 | $21.8M | Buy |
452,189
+39,970
| +10% | +$1.77M | ﹤0.01% | 1623 |
|
|
2024
Q1 | $19.8M | Buy |
412,219
+6,186
| +2% | +$330K | ﹤0.01% | 1619 |
|
|
2023
Q4 | $26.4M | Buy |
406,033
+5,986
| +1% | +$360K | 0.01% | 1419 |
|
|
2023
Q3 | $26.2M | Buy |
400,047
+14,728
| +4% | +$927K | 0.01% | 1320 |
|
|
2023
Q2 | $22.4M | Buy |
385,319
+26,959
| +8% | +$1.7M | 0.01% | 1416 |
|
|
2023
Q1 | $22.1M | Sell |
358,360
-208
| -0.1% | -$12.5K | 0.01% | 1391 |
|
|
2022
Q4 | $22.8M | Buy |
358,568
+9,024
| +3% | +$654K | 0.01% | 1341 |
|
|
2022
Q3 | $25.4M | Buy |
349,544
+77,298
| +28% | +$5.76M | 0.01% | 1212 |
|
|
2022
Q2 | $18.5M | Buy |
272,246
+29,312
| +12% | +$2.11M | 0.01% | 1466 |
|
|
2022
Q1 | $22M | Sell |
242,934
-9,008
| -4% | -$737K | 0.01% | 1471 |
|
|
2021
Q4 | $23M | Buy |
251,942
+12,066
| +5% | +$1.03M | 0.01% | 1473 |
|
|
2021
Q3 | $19.5M | Buy |
239,876
+128,063
| +115% | +$10.8M | 0.01% | 1611 |
|
|
2021
Q2 | $10.4M | Buy |
111,813
+38,167
| +52% | +$3.7M | ﹤0.01% | 1978 |
|
|
2021
Q1 | $7.88M | Buy |
73,646
+15,685
| +27% | +$1.63M | ﹤0.01% | 2078 |
|
|
2020
Q4 | $5.06M | Buy |
57,961
+223
| +0.4% | +$15.8K | ﹤0.01% | 2208 |
|
|
2020
Q3 | $3.99M | Buy |
57,738
+52,228
| +948% | +$3.36M | ﹤0.01% | 2190 |
|
|
2020
Q2 | $267K | Buy |
+5,510
| New | +$263K | ﹤0.01% | 3094 |
|
Other funds holding NARI
SA
IA
TCWM
PS